Prediction of clinical outcome of fluoropyrimidine-based chemotherapy for gastric cancer patients, in terms of the 5-fluorouracil metabolic pathway
- 25 August 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in Gastric Cancer
- Vol. 9 (3), 145-155
- https://doi.org/10.1007/s10120-006-0373-8
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Current status and future prospects of chemotherapy for metastatic gastric cancer: a reviewGastric Cancer, 2005
- Combined GADD45A and Thymidine Phosphorylase Expression Levels Predict Response and Survival of Neoadjuvant-Treated Gastric Cancer PatientsClinical Cancer Research, 2005
- Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatmentThe Lancet Oncology, 2005
- The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response to 5′-deoxy-5-fluorouridineEuropean Journal of Cancer, 2004
- Low Thymidylate Synthase Expression in the Primary Tumor Predicts Favorable Clinical Outcome in Resected Gastric Cancer Patients Treated with Adjuvant TegafurOncology, 2004
- Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracilEuropean Journal of Cancer, 2004
- Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinomaInternational Journal of Clinical Oncology, 2003
- Dihydropyrimidine Dehydrogenase and Messenger RNA Levels in Gastric Cancer: Possible Predictor for Sensitivity to 5-FluorouracilJapanese Journal of Cancer Research, 2000
- Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: Preliminary report from an ongoing trialEuropean Journal of Cancer, 1995
- 5-fluorouracil and uft-sensitive gastric carcinoma has a high level of thymidylate synthaseCancer, 1989